Captopril

CAS 62571-86-2 7 current records 4 historicalSmall Molecule

Who holds supplier records for Captopril? 7 organisations hold a current record for Captopril: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), Spain (3) and India (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Captopril: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/captopril

Reading the evidence

  • 7 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (7)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Captopril. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Captopril sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Captopril, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 1997-023 - Rev 10
Captopril
Oct 2020—
ZHONGFU PHARMACEUTICAL CO., LTD. Weifang CityCN
R1-CEP 2003-113 - Rev 02
Captopril
Oct 2016—
Wockhardt Limited MumbaiIN
R1-CEP 1998-052 - Rev 04
Captopril
Jun 2014—
Farmhispania, S.A. MontmelóES
R1-CEP 1997-018 - Rev 06
Captopril
Mar 2011—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Captopril are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • SINOVA PHARMACEUTICALS CO PTE LTD
    Inactive DMF 12672 · filed Sept 1997
  • BORYUNG PHARMACEUTICAL CO LTD
    Inactive DMF 11228 · filed Dec 1994
  • SHANDONG WEI FANG PHARMACEUTICAL FACTORY
    Inactive DMF 9745 · filed Jun 1992
  • Hungary · Inactive DMF 9221 · filed Jul 1991

Overview

Captopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and certain types of heart failure. It works by relaxing blood vessels and reducing blood pressure, improving blood flow and oxygen supply to the heart.

Chemical identity

IUPAC name
(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Canonical SMILES
C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
InChIKey
FAKRSMQSSFJEIM-RQJHMYQMSA-N
Synonyms
Capoten API, apopril, c09aa01, capoten, captomax, captoprilum, farcopril, garranil, hypopress, mepha, nsc-757419, sa-333

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin Converting Enzyme Inhibitor
Mechanism of action
Angiotensin-converting Enzyme Inhibitors

Therapeutic areas

CardiovascularRenalEndocrine

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Captopril?

7 organisations hold an active US FDA Type II Drug Master File or a CEP for Captopril: Wockhardt Limited (India), Zhejiang Huahai Pharmaceutical Co., Ltd. (China), Zhongfu Pharmaceutical Co., Ltd. (China), CHANGZHOU PHARMACEUTICAL FACTORY (China), MEDICHEM SA (Spain), QUIMICA SINTETICA SA (Spain) and FARMHISPANIA SA (Spain). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Captopril Drug Master Files are active?

Wockhardt Limited (DMF 8028), Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 14311), Zhongfu Pharmaceutical Co., Ltd. (DMF 11905), CHANGZHOU PHARMACEUTICAL FACTORY (DMF 33888), MEDICHEM SA (DMF 9770, 32247) and QUIMICA SINTETICA SA (DMF 8460). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Captopril records mean?

4 organisations have only inactive Type II DMFs for Captopril. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Captopril have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Captopril on the EDQM register, including ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai (CN), ZHONGFU PHARMACEUTICAL CO., LTD. Weifang City (CN), Wockhardt Limited Mumbai (IN) and Farmhispania, S.A. Montmeló (ES). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Captopril supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Captopril?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.